House of Lords Select Committee on Science and Technology. Session 1998, 7th report, 1–108. Resistance to antibiotics and other antimicrobial agents. Chairman – Lord Soulsby. London: The Stationery Office.
2.
Anonymous. Proposal for a council recommendation on the prudent use of antimicrobial agents in human medicine. Official Journal of the European Communities2001; L 34/13: 13501–13502.
3.
Antimicrobial Resistance Strategy and Scottish Action Plan. Scottish Executive Health Department, Edinburgh2002.
4.
Antimicrobial Prescribing, Policy and Practice in Scotland: ecommendations for good antimicrobial practice in acute hospitals. Scottish Medicines Consortium/Healthcare Associated Infection Task Force. Scottish Executive, Edinburgh2005.
5.
Critical Care National Cost Block Programme - Annual Report2003 – 2004. Medical Economics Research Centre, Sheffield.
6.
HarbarthSPittetD. Excess mortality and impact of intensive care unit-acquired infections. Curr Opin Anaes1996; 9: 139–145.
7.
WeberDRaaschRRutalaW. Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens. Chest1999; 115: 31s–41s.
WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD index 2005: about the ATC/DDDsystem. www.whocc.no/atcddd.
10.
ShetkaMPastorJPhelpsP. Evaluation of the defined daily dose method for estimating antiinfective use in a university hospital. Am J Health-Syst Pharm2005; 62: 2288–2292.
11.
MeyerEJonasDSchwabFDesign of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection2003; 31: 208–215.
12.
MeyerESchwabFJonasDSurveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units. Intensive Care Med2004; 30: 1089–1096.
13.
EdbrookeDHibbertCCorcoranM. Review for the NHS Executive of adult critical care services: an international perspective. Medical Economics and Research Centre, Sheffield1999.
14.
FiliusPLiemTvan der LindenPAn additional measure for quantifying antibiotic use in hospitals. JAC2005; 55: 805–808.
15.
CarletJBen AliAChalfineA. Epidemiology and control of antibiotic resistance in the intensive care unit. Curr Opin Infect Dis2004; 17: 309–316.
16.
BontenMWeinsteinR. Antibiotic cycling in intensive care units: the value of organised chaos?Crit Care Med2006; 34: 549–551.
17.
GoldmanDWeinsteinRWenzelRStrategies to prevent and control the emergence and spread of antimicrobial-resistant micro-organisms in hospitals. A challenge for medical leadership. JAMA1996; 275: 234–240.